Skip to main content

Remote Job Finders (RJF)

Cellares, which last year became the first company to receive the FDA’s new advanced manufacturing technology designation, expects to support clinical production this year and offer commercial-scale manufacturing services in 2027.
BMS-Partnered Cellares Raises $257M for Cell Therapy Manufacturing Expansion
Scroll to top